Filing Details

Accession Number:
0001493152-21-010669
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-06 13:00:00
Reporting Period:
2021-05-04
Accepted Time:
2021-05-06 18:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412486 Cocrystal Pharma Inc. COCP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397607 F Raymond Schinazi 1860 Montreal Road
Tucker GA 30084
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-04 575,000 $2.95 7,674,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $2.60 to $3.25, inclusive. The Reporting Person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnote (1) to this Form 4.